Zobrazeno 1 - 10
of 141
pro vyhledávání: '"Stephanie L, Lee"'
Publikováno v:
Frontiers in Endocrinology, Vol 15 (2024)
ObjectiveGray-scale ultrasound (US) is the standard-of-care for evaluating thyroid nodules (TNs). However, the performance is better for the identification of hypoechoic malignant TNs (such as classic papillary thyroid cancer) than isoechoic malignan
Externí odkaz:
https://doaj.org/article/8fdcf7112d844368a73a23695aeaf714
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Externí odkaz:
https://doaj.org/article/46f9aa83890c4a1993fb88fa6577efd2
Publikováno v:
Therapeutic Advances in Endocrinology and Metabolism, Vol 13 (2022)
Cushing’s syndrome (CS) is an endocrine disease characterized by excessive adrenocortical steroid production. One of the mainstay pharmacological treatments for CS are steroidogenesis enzyme inhibitors, including the antifungal agent ketoconazole a
Externí odkaz:
https://doaj.org/article/2c9b5a67afdd4a04b2cc3dc47bd2e49a
Autor:
Poorani N. Goundan, Jonathan Mamou, Daniel Rohrbach, Jason Smith, Harshal Patel, Kirk D. Wallace, Ernest J. Feleppa, Stephanie L. Lee
Publikováno v:
Frontiers in Endocrinology, Vol 12 (2021)
BackgroundGray-scale, B-mode ultrasound (US) imaging is part of the standard clinical procedure for evaluating thyroid nodules (TNs). It is limited by its instrument- and operator-dependence and inter-observer variability. In addition, the accepted h
Externí odkaz:
https://doaj.org/article/c231df62b46f413ba0d046a40807f18c
Autor:
Jochen H. Lorch, Pasi A. Jänne, Stephanie L. Lee, Ellen Marqusee, Matthew Nehs, Tom Thomas, Krystof Misiwkeiwicz, Francis D. Moore, Erik K. Alexander, Sewanti A. Limaye, Anne O'Neill, Guilherme Rabinowits, Maria E. Cabanillas, Stefan Kraft, Robert I. Haddad, Antonio Calles, Justine A. Barletta, Lori J. Wirth, Nicole G. Chau, Naifa L. Busaidy, Glenn J. Hanna
Supplementary Table S2. Clinical response and outcomes to everolimus in patients with advanced differentiated thyroid cancers by histologic subgroup
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3955f6964c6f6bbf2604945400a44ae5
https://doi.org/10.1158/1078-0432.22465415.v1
https://doi.org/10.1158/1078-0432.22465415.v1
Autor:
Jochen H. Lorch, Pasi A. Jänne, Stephanie L. Lee, Ellen Marqusee, Matthew Nehs, Tom Thomas, Krystof Misiwkeiwicz, Francis D. Moore, Erik K. Alexander, Sewanti A. Limaye, Anne O'Neill, Guilherme Rabinowits, Maria E. Cabanillas, Stefan Kraft, Robert I. Haddad, Antonio Calles, Justine A. Barletta, Lori J. Wirth, Nicole G. Chau, Naifa L. Busaidy, Glenn J. Hanna
Purpose: Targeting mutations leading to PI3K/mTOR/Akt activation are of interest in thyroid cancer. We evaluated the efficacy of everolimus in aggressive, radioactive iodine–refractory (RAIR) thyroid cancer and correlated tumor mutational profiling
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a564e905d144c00cdb9917bc4b2bfca
https://doi.org/10.1158/1078-0432.c.6526016
https://doi.org/10.1158/1078-0432.c.6526016
Publikováno v:
Frontiers in Endocrinology, Vol 9 (2018)
Objectives: To examine the prevalence of genetic alterations of thyroid-stimulating hormone receptor (TSHR) gene and sodium-iodine symporter (NIS) in a series of thyroid fine needle biopsy (FNB) specimens with indeterminate cytology, and to assess th
Externí odkaz:
https://doaj.org/article/bdb73c6866f14e8983fd5078a1089ccc
Publikováno v:
Endocrine Practice. 27:216-222
Objective The sensitivity of thyroglobulin (Tg) to detect differentiated thyroid cancer recurrence increases with the rise of the thyrotropin level. Since 1998, recombinant human thyrotropin (rhTSH) has been commercially available for this purpose. T
Publikováno v:
New England Journal of Medicine. 383:2275-2281
Looking for the Outsider A 44-year-old man presented with fatigue, unintentional weight loss, and a 2-year history of hip and chest-wall pain. He had earlier presented with acute right clavicle pai...
Autor:
Gianluca Toraldo, David Kindelberger, Razie Amraei, Bradely Zehr, Shoreh R Fazeli, Haixia Guan, Stephanie L. Lee, Sandra Cerda
Publikováno v:
Thyroid. 30:1528-1534
Background: Novel molecular tests (MTs), such as ThyroSeq, may improve the management of thyroid nodules with indeterminate cytologic diagnoses; however, the impact of these tests on cost and outco...